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Abstract
Background: Urate oxidase (EC 1.7.3.3 or UOX) catalyzes the conversion of uric acid and
gaseous molecular oxygen to 5-hydroxyisourate and hydrogen peroxide, in the absence of cofactor
or particular metal cation. The functional enzyme is a homo-tetramer with four active sites located
at dimeric interfaces.
Results: The catalytic mechanism was investigated through a ternary complex formed between the
enzyme, uric acid, and cyanide that stabilizes an intermediate state of the reaction. When uric acid
is replaced by a competitive inhibitor, no complex with cyanide is formed.
Conclusion:  The X-ray structure of this compulsory ternary complex led to a number of
mechanistic evidences that support a sequential mechanism in which the two reagents, dioxygen
and a water molecule, process through a common site located 3.3 Å above the mean plane of the
ligand. This site is built by the side chains of Asn 254, and Thr 57, two conserved residues belonging
to two different subunits of the homo-tetramer. The absence of a ternary complex between the
enzyme, a competitive inhibitor, and cyanide suggests that cyanide inhibits the hydroxylation step
of the reaction, after the initial formation of a hydroperoxyde type intermediate.
Background
Urate oxidase (uricase; EC 1.7.3.3; or UOX) belongs to the
purine degradation pathway and catalyzes in the presence
of molecular oxygen the hydroxylation of uric acid into a
metastable product identified as the 5-hydroxyisourate
(5-HIU) [1]. Once released in solution, 5-HIU decays
slowly to allantoin, a process independent of oxygen and
associated with the release of CO2 (dehydro-decarboxyla-
tion).). In vivo, 5-HIU is rapidly processed by two specific
enzymes to [S]-allantoin [2,3], the structures of which
were solved [4,5]. Urate oxidase is present in many spe-
cies, but is absent in human and higher apes. This empha-
sizes an evolutionary advantage since it was suggested that
uric acid being a powerful anti-oxidant, humans would
have less free radicals, so less cancer due to aging. As a
consequence, uric acid level in plasma is quite elevated
and a higher pathological level may be fatal. Sanofi-
Aventis produces and commercializes urate oxidase, first
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extracted from Aspergillus flavus and now expressed in Sac-
charomyces cerevisiae, branded under the name Fasturtec®
(DCI : Rasburicase), to prevent hyperuricemia that can
happen during chemotherapies of children.
The  Aspergillus flavus urate oxidase crystallizes in the
orthorhombic system, space group I222. The asymmetric
unit contains one monomer of 301 amino-acids and the
whole tetramer is built using the two-fold axes of the cur-
rent I222 crystal symmetry. The complete structure has the
shape of a barrel 70 Å high, with an inner and outer radius
of about 6 Å and 30 Å, respectively [6]. Each monomer is
associated with one active site located at a dimer interface.
The four active sites are accessible from the external sur-
face of the tetramer. The role and significance of the cen-
tral void channel still remains unknown.
The catalytic mechanism of urate oxidase is original since
it does not imply any cofactor or metal ion, questioning
about how urate, a singlet, can react with oxygen, a triplet.
Several X-ray structures with, or without uric acid ana-
logues have already been determined to unravel the three-
dimensional active site topology [7,8]. Grown in presence
of uric acid (the natural substrate), the crystalline func-
tional enzyme readily degrades its substrate and catches
back (Kd ~10-7) the final product of the reaction cascade,
the S-allantoin [9]. Under dioxygen pressure, and in the
presence of the competitive inhibitor 8-azaxanthine (8-
AZA), the location of molecular oxygen in the active site
was recently characterized giving information about the
first step of the reaction [10]. Here, in the presence of
sodium cyanide, known to compete with dioxygen [11],
we crystallize a non productive ternary [UOX/uric acid/
cyanide] complex, that shows for the first time the natural
substrate within the active site of UOX. In the same struc-
ture, a cyanide ion is observed at the location occupied by
molecular oxygen in the first step of the mechanism [10]
or by a water molecule in the following hydroxylation
step of the reaction [7,8]. All attempts to crystallize a ter-
nary [UOX/8-AZA/cyanide] complex prevent any cyanide
anion to be observed in the crystal structure.
Results
In normal reactive conditions, UOX crystals grown in the
presence of uric acid lead to a complex between the pro-
tein and the final product of degradation, S-allantoin
showing the high affinity of UOX for the last product of
the reaction cascade [9]. The electron density map of the
ternary [UOX/UA/CN] crystal structure shows a density
clearly corresponding to the natural substrate that was
never observed before because of its rapid degradation by
the enzyme. The elongated density observed at stacking
distance (3.3 Å) of the mean-plane of urate, and attributed
to the expected cyanide anion, fills a site where either a
dioxygen or a catalytic water molecule have been previ-
ously observed [10] – Figure 1. This represents so far the
first observation of a non heme-complexed cyanide ion in
a crystalline structure. On the contrary, in the complex
with the 8-AZA inhibitor, no equivalent signature of cya-
nide could be observed and the perfect spherical density
at the cyanide location indicates that the catalytic water is
still present with its centroid corresponding to the nitro-
gen atom of the cyanide. We then conclude that the sub-
strate and the cyanide ion are both necessary for the
formation of a stable and non-productive intermediate
state.
Compared to the structure of a previously solved non-cya-
nide 8-AZA complex [UOX/8-AZA] (2iba from PDB), both
complexes, the ternary [UOX/UA/CN] and the [UOX/8-
AZA] crystallized in cyanide, show very little deviation on
coordinates with an average r.m.s.d of 0.19 Å over all the
main chain atoms. However, an important feature distin-
guishes complexes crystallized with cyanide from the oth-
ers. At pH above 9, that invariably occurs upon addition
of a cyanide excess, a flip of the His 98 is observed with a
χ1 angle moving from -60° to 180°, leading to a complete
rearrangement of the hydrogen bond network in this
region. In all previously solved structures at pH below (or
close to) 9, the imidazole group of His 98 was observed as
a positively charged group because it is hydrogen bonded
on both sides to carboxylates of Asp 100 and Glu 131.
Increasing the pH above 9 by cyanide addition favors an
uncharged His 98 at the origin of this drastic rearrange-
ment.
The different structures already solved with urate-like
inhibitors have shown that the ligand is stacked with phe-
nylalanine 159 and always hydrogen-bonded to the
enzyme through a molecular tweezers (the "ligand tweez-
ers") composed by the two invariant residues arginine 176
and glutamine 228 [7,8]. In [UOX/UA/CN], the urate sub-
strate (Figure 1) is exactly positioned as observed in all
other inhibited UOX structures (this includes 8-azaxan-
thine, xanthine, 8-nitroxanthine, 9-methyl uric acid,
oxonic acid and di-aminouracil). On top of the ligand, at
a distance of 3.3 Å, the catalytic water molecule W1, usu-
ally hydrogen bonded by the "reagent tweezers" built by
the side-chains of asparagine 254 and threonine 57* from
a symmetric subunit [7-9], is now replaced by a cyanide
anion. When the "reagent tweezers" holds a single water
molecule, the distance between the Oγ and Nδ2 atoms of
the tweezers is remarkably constant (5.53 ± 0.05 Å) as
shown in structures 1r4u, 1wrr, 1xxj, 1xt4, and 2iba from
the PDB. In the [UOX/8-AZA] structure crystallized in cya-
nide, this distance falls within these limits (5.48 Å), an
additional argument defending the lack of cyanide in the
electron density. In the case of the ternary [UOX/UA/CN]
complex, the cyanide insertion now significantly increases
this distance up to 5.89 Å, close to what is observed in theBMC Structural Biology 2008, 8:32 http://www.biomedcentral.com/1472-6807/8/32
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oxygen-pressurized [UOX/O2/8-AZA] structures 2zka,
2zkb or 3cks [10], a feature underlining the flexibility of
this motif. When the reagent tweezers is void of any lig-
and, like in 1r56 or 1xy3 structures, the distance increase
up to 6 Å.
In addition, W1 and the Oγ of Thr 57* (building the per-
oxo hole) are the starting point of a complex proton relay
including Lys 10*, His 256, and two water molecules,
ending to W2 and to the N9 atom of the ligand, as shown
in Figure 2 and 3. However, Thr 57* in [UOX/UA/CN],
cannot act as a base because of the charged cyanide ion.
The threonine 57* becomes a proton donor instead and
as a result, the extended electron relay through the already
mentioned Lys 10* and His 256 residues is interrupted as
shown by the increased distance of 3.5 Å between Lys 10*
and Thr 57* (Figure 3).
All the ligands so far observed in the peroxo hole (water,
oxygen, cyanide, chloride ..) are always tightly bound as
illustrated by low thermal B factors, full occupancy factors
– Table 1) and well defined electron densities, including
the Lys 10* side-chain.
Discussion
As mentioned above, the catalytic mechanism of urate
oxidase is of particular interest because UOX is a cofactor-
less enzyme that requires no special assistance [12]. Iso-
topic labeling experiments have proved that the oxygen
atoms of hydrogen peroxide derived from dioxygen and
that the oxygen atom attached to C5 in the product
derived from a water molecule [13]. NMR and spectro-
scopic studies have shown that UOX transforms the urate
anion in a metastable compound identified as 5-hydrox-
yisourate (5-HIU) [1,14-16] and not allantoin. In addi-
Omit-map showing the electron density corresponding to the two partners of the [UOX/UA/CN] complex, the cyanide and  uric acid Figure 1
Omit-map showing the electron density corresponding to the two partners of the [UOX/UA/CN] complex, 
the cyanide and uric acid. The active site is delimited by 1) the conserved residues implicated in the molecular tweezers 
(Arg 176, Glu 228) that holds the substrate, 2) the Phe 159 closing one end of the cavity below, and 3) the two Asn 254 and 
Thr 57* forming another tweezers above the mean plane of the ligand that construct a location where efficient electron trans-
fer can take place at a low energy level via the catalytic triad Thr 57* Lys 10* His 256, and the associated water molecules 
shown in Figure 3). The orientation of cyanide is based on a coherent evolution of the C/N thermal factors during refinements, 
compared to neighboring atoms (stereo view).BMC Structural Biology 2008, 8:32 http://www.biomedcentral.com/1472-6807/8/32
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tion, it was suggested from stop-flow kinetics experiments
that urate hydro-peroxide would be a primary intermedi-
ate, presumably through the addition of a superoxide rad-
ical O2-. [16]. Although this intermediate was not firmly
established, the structural similarities between UOX,
pterin and other reduced flavin proteins reinforces this
suggestion [17].
Following a number of observations and spectroscopic
results, a multi-step mechanism, summarized in Figure 2,
was proposed [10,18,19]. In this model, stepwise addi-
tions of dioxygen and a water molecule occur sequentially
via the same catalytic site (the peroxo hole). Further, a
recent EPR investigation of the reaction [20] demon-
strated that intermediates are essentially radicals and not
ionic species as indicated in Figure 2. As imperfect as this
model can be, it represents up to now the best hypothesis
for this particular mechanism.
Mono-urate, di-urate or dehydrourate anions in the active 
site?
Two distinct enzymatic intermediates were proposed in
the initial steps of the urate oxidase reaction, the urate
dianion and 5-hydroperoxyisourate (5-HPIU), based on
their spectral signatures [16] – Scheme 1. At the end of the
first step, the elimination of hydrogen peroxide from 5-
HPIU would yield to dehydrourate that is not experimen-
tally observed [18], probably because it does not accumu-
late during the enzymatic turnover. The final step of the
reaction is the rapid nucleophilic addition of a hydroxyl
group deriving from water W1 onto dehydrourate to give
5-HIU and a re-protonation by the water molecule W2
(Figures 1 and 3). The characterization of discrete inter-
mediates during the urate oxidase reaction ruled out any
concerted mechanism in which W1 would attack at C5
simultaneously with direct electron transfer from urate to
oxygen.
The reaction pathway from compiled data [10,18,19] Figure 2
The reaction pathway from compiled data[10,18,19]. Although the use of Lewis-type representation is inadequate for 
strongly mesomeric structures (radicals or anions), this sketches about the different intermediates 1to 4involved in the mech-
anism leading to 5-HIU, 5.
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Since the urate pk's are 5.3 and 10.3, the mono N3-depro-
tonated form of the substrate is likely to be the species
which first binds at biological pH. At high pH, non-enzy-
matic solution studies (voltametric) have shown a more
facile oxidation of the dianion form of urate than the
monoanion [21]. The formation of urate dianion after
binding was evidenced and proposed to result from the
predicted action of an unprotonated residue involved in a
base catalysis [12,22]. Quantum mechanic calculations
are in agreement of the [N3- N7-] dianion as it displays the
lowest ionization potential once complexed in the active
site and as such becomes the most eligible to give sponta-
neously one of its electrons to an acceptor species [23].
Mutation of critical residues [18] suggested that a threo-
nine involved in the active site may be a good candidate
to act as the expected general base in the deprotonation.
The X-ray structure suggests that the proton transfer to the
solvent by a lysine [18] is in relay with an histidine [10]
and assisted by several water molecules. This complex
relay, which initiates at the catalytic water molecule W1
and terminates at W2 the water molecule that re-proto-
nates the N9 atom of the ligand (Figure 3), is thus able to
play the role of a "proton shuttle" in the reaction.
Obviously, the X-ray structure of this ternary complex rep-
resents a static view of an intermediate state of the reac-
tion and question arises about the exact ionic state of the
bound ligand observed in the active site (Figure 1). A sur-
vey of the protonation state at proximity of the ligand,
although hydrogen atoms cannot be directly observed in
the electron density, indicates that two of them are not
The superimposition of the catalytic triad TKH in the two structures [UOX/UA/CN] and [UOX/8-AZA] crystallized in cyanide Figure 3
The superimposition of the catalytic triad TKH in the two structures [UOX/UA/CN] and [UOX/8-AZA] crys-
tallized in cyanide. This shows how the cyanide present in the first structure influences the H-bond network (black dotted 
lines for cyanide/uric acid and pink dotted lines for 8-AZA complexes). The permanent negative charge of the cyanide induces 
a drastic change in the H-bond network continuity with a nearly broken Thr 57* – Lys 10* connection (3.51 Å compared to 
2.86 Å in the non-cyanide 8-AZA complex). A similar discontinuity is observed when a chloride anion is located in the oxygen/
W1 hole [10].BMC Structural Biology 2008, 8:32 http://www.biomedcentral.com/1472-6807/8/32
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present as deduced from the donor/acceptor state of the
side chains around it. According to this, it is likely that the
nearly flat electron density observed in the active site
would not correspond to mono-urate but can be either the
urate dianion [N3- N7-] (intermediate 2 in Figure 2), the
radical mono anion, or the dehydrourate mono anion
(intermediate 4 in Figure 2).
Inhibition by cyanide
It is known that UOX is inhibited in solution by cyanide
with a loss of activity of 90 % [11,24,25]. The same holds
for azide, but at a lesser extent [25], questioning at that
time about the presence of a heavy metal in the active site,
as many metallo-oxidases are analogously poisoned by
cyanide. For example, irreversible inhibition is observed
when xanthine oxidase is incubated with cyanide in the
absence of substrate. By analogy, cyanide was assumed to
interact with the dioxygen site in UOX, although not
involved in the formation of any intermediate structure
[26]. However, compared to xanthine oxidase, the inhibi-
tion of UOX by cyanide is non competitive versus urate,
increases with time, and is perfectly reversible [11].
The location of the cyanide anion, which replaces either
the molecular dioxygen involved in the hydroperoxy
intermediate formation, or the water molecule (W1)
involved in the hydroxylation of the dehydrourate inter-
mediate, suggests that the cyanide inhibits any access to
the peroxo hole during the course of the reaction. When
urate,  14C-labeled cyanide, and dioxygen are present
together in the incubation mixture, a labelled enzyme
complex is detected [11]. Removing one of the three com-
ponents from the incubation mixture, or replacing either
O2 by N2, did not show the formation of a labeled com-
plex. Due to a packing effect, this experiment would be
difficult to interpret in the crystalline state, because of
additional labelings at interfaces. We have undertaken
NMR experiments in solution using 13C cyanide to con-
firm these results. A clear signal corresponding to a bound
ion to the protein is observed in presence of oxygen and
uric acid. No labeling is observed when urate is replaced
by 8-AZA, an observation that may explain why no cya-
nide is observed in the [UOX/8-AZA/CN] structure. More-
over, the initial velocity of urate transformation in the
absence of cyanide did not change after extensive pre-
Table 1: Crystallographic data collection and refinement statistics. The two structures are orthorhombic, space group I222.
Complex structure [UOX/UA/CN] [UOX/8-AZA/CN]
Unit cell parameters (Å)
a = 79.94 79.72
b = 94.99 95.10
c = 104.29 103.96
Resolution range (Å) * 30 – 1.8 (1.9 – 1.8) 30 – 1.6 (1.7 – 1.6)
No of measured reflections* 147 946 (20 420) 255 591 (36 780)
No of unique reflections* 35 679 (5250) 51 972 (7545)
Rmerge (%) overall * 6.4 (22.6) 4.4 (10.4)
Completeness (%) * 96.6 (98.4) 99.5 (100)
Redundancy * 4.1 (3.9) 4.9 (4.9)
Refinements:
Rwork (%)# 21.8 20.0
Rfree (%)¥ 24.0 22.2
No of waters 234 279
Average thermal factors (Å2)
Main chain atoms: 16.6 14.7
Side-chain atoms: 21.2 18.7
Water molecules: 25.2 26.3
Ligands (CN-): 15.5 (Urate): 13.4 (W1): 10.6 (8-AZA): 11.2
Rms Deviations:
Bond distances (Å) 0.006 0.005
Bond angles (°) 1.3 1.4
Planes (Å) 0.21 0.19
Chiral Volumes (Å3) 0.030 0.035
PDB access number 3BJP 3BK8
* Last shell values are given in parentheses.
# The crystallographic R-factor is defined as ∑|Fo| - |Fc|/∑|Fo|
¥Calculated using 8 percent of the native data, which were randomly chosen and excluded from refinementsBMC Structural Biology 2008, 8:32 http://www.biomedcentral.com/1472-6807/8/32
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incubation of the enzyme with cyanide [11]. These results
suggest more precisely the generation of a cyanide inhibi-
tor site in the simultaneous presence of the two substrates,
urate and O2. Thus, cyanide presumably reacts once an
intermediate already oxidized by O2 is formed. Moreover,
the presence of a dianion and a charged cyanide, that rep-
resent three negative charges in the same closed environ-
ment, would be an energetically non favorable situation.
In these conditions, it is likely that the flat electron density
observed in the active site (Figure 1) would best corre-
spond to the second stage of the reaction, i.e. the com-
plexed dehydrourate intermediate rather than the urate
dianion (Figure 2). This supports that cyanide would
mainly compete reversibly with water in the second step
of the reaction rather than oxygen in the first step.
Conclusion
Two non-productive ternary complexes of urate oxidase
that mimic two different stages of the reaction are now
available: the first structure [UOX/8AZA/O2], with 8-aza-
xanthine, an analogue of uric acid, and oxygen recently
determined [10] and the present structure [UOX/UA/CN-
], which includes the natural substrate and cyanide, a
competing inhibitor of oxygen. This allows us to charac-
terize the two reaction partners within the active site and
derive additional information about the mechanism.
First, we confirm that in all cases, the enzyme holds either
uric acid or its analogues in the same orientation within
the active site. Second, the oxygen site previously charac-
terized [10] is occupied by a cyanide ion only when the
natural substrate is present, suggesting that the binding of
uric acid must precede in normal conditions the binding
of dioxygen. As such, these two UOX complexes describe
two different intermediate steps of the reaction pathway
and suggest a common catalytic site where both di-oxygen
and water (and probably hydrogen peroxide) are sequen-
tially driven. This mechanism shares important similari-
ties with other cofactor-less oxidases [27], and also with
catalase, the enzyme that performs the reverse reaction of
hydrogen peroxide to dioxygen, also known to sequen-
tially drive hydrogen peroxide and water molecules
through a common catalytic site [28].
Methods
Purified recombinant urate oxidase (UOX) from A. flavus,
expressed in S. cerevisiae, was supplied by Sanofi-Aventis
Co. The crystals of the ternary [UOX/uric acid/cyanide]
complex [UOX/UA/CN] were grown following the batch
technique at room temperature, using conditions slightly
modified from [29]. 5–10 mg/ml protein was dissolved in
50 mM Tris/HCl pH 8.5 and NaCN 0.2 M. To the solution,
10–15% w/v PEG 8000 was added. After a rapid mixing,
orthorhombic crystals started growing within a few hours.
They were rapidly harvested, before they develop to full
size and immediately transferred in a cryoprotectant mix-
ture of the same crystallizing solution plus 20 % v/v of
2,4-dimethyl pentane diol (MPD), or ethylene glycol for
one minute, then flash-cooled in liquid nitrogen. The
same process was followed and the same crystalline form
obtained when replacing uric acid by its analogue 8-azax-
anthine [UOX/8-AZA/CN] in the crystallization medium.
X-ray data collections were carried out at the ESRF (Greno-
ble, France) BM14 beam line, at a wavelength of 0.978 Å,
operating in the 16 bunch mode, using a MAR CCD detec-
tor. The temperature was set to 100 K. Data were inte-
grated by the MOSFLM program [30], amplitudes were
derived after merging and scaling using the SCALA and
TRUNCATE programs [31]. The starting model for rigid
body refinement was taken from the refined UOX in com-
plex with 8-nitro-xanthine [UOX/8-NXN], the coordi-
nates of which were refined at a near atomic resolution
(Gabison et al., in preparation) after removing the water
molecules and the ligand. Structure refinement was car-
ried out by CNS [32]. The graphics program O [33] was
used to visualize |2Fobs - Fcalc|, |Fobs - Fcalc|, and omit
electron-density maps and for manual refittings.
[UOX/UA/CN] complex
Following two steps of positional and thermal parameters
refinement, an electron density map was calculated show-
ing a density corresponding clearly to the natural sub-
strate (Figure 1). In addition, the elongated electron
density, about 3.3 Å near the mean plane of urate was
attributed to the expected cyanide anion, at a location
where a water molecule is always present in other inhib-
ited UOX structures. The ligand coordinates determined
by semi-empirical calculations [34] were then included in
the structure, as well as the cyanide. The complete model
was improved by subsequent refinement cycles followed
by manual re-fitting of some residues in the electron den-
sity, including Arg 7, His 98, and Gln 131 side chains. Par-
ticular attention was taken about the solvent molecules by
examining their interactions and the spherical shape of
their electron density.
[UOX/8-AZA] cyanide complex
Equivalent protocol for refinements was adopted, using
the CNS program in a similar way. The 8-AZA coordinates
were taken from a previously equivalent structure (2IBA,
Protein Data Bank). However, no signature of the cyanide
ion was visible in subsequent improved electron differ-
ence maps.
The two coordinate data sets were deposited with the Pro-
tein Data Bank (ref. number 3BJP and 3BK8). As evaluated
by PROCHECK [35], all non-glycine residues fall within
the energetically favorable regions of a Ramachandran
plot [36]. The figures were prepared using PYMOL [37].BMC Structural Biology 2008, 8:32 http://www.biomedcentral.com/1472-6807/8/32
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Summaries of the data collection statistics and refine-
ments for the two structures are shown in table 1.
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